Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK2983559 free acid is a specific and orally bioavailable inhibitor of receptor-interacting protein 2 (RIP2) kinase. It has excellent activity in blocking many proinflammatory cytokine responses in vivo and in human inflammatory bowel disease explant samples.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 10,000 | |||
5 mg | 在庫あり | ¥ 22,500 | |||
10 mg | 在庫あり | ¥ 34,500 | |||
25 mg | 在庫あり | ¥ 58,000 | |||
50 mg | 在庫あり | ¥ 86,000 | |||
100 mg | 在庫あり | ¥ 129,500 |
説明 | GSK2983559 free acid is a specific and orally bioavailable inhibitor of receptor-interacting protein 2 (RIP2) kinase. It has excellent activity in blocking many proinflammatory cytokine responses in vivo and in human inflammatory bowel disease explant samples. |
分子量 | 538.53 |
分子式 | C21H23N4O7PS2 |
CAS No. | 1579965-12-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 4.5 mg/mL (8.36 mM), Sonication and heating to 80℃ are recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK2983559 free acid 1579965-12-0 Apoptosis NF-Κb Others RIP kinase inhibit THP-1 cell GSK 2983559 Inhibitor GSK-2983559 RIPK Receptor-interacting protein kinases GSK-2983559 free acid GSK2983559 inhibitor